Clearstead Advisors’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.34M Buy
8,397
+3,616
+76% +$1.58M 0.03% 305
2026
Q1
$2.2M Sell
4,781
-3,573
-43% -$1.81M 0.02% 342
2025
Q4
$4.73M Buy
8,354
+2,932
+54% +$1.56M 0.06% 209
2025
Q3
$2.42M Buy
5,422
+329
+6% +$158K 0.03% 292
2025
Q2
$2.77M Buy
5,093
+1,811
+55% +$947K 0.04% 267
2025
Q1
$1.63M Sell
3,282
-33
-1% -$18.3K 0.03% 335
2024
Q4
$1.73M Sell
3,315
-70
-2% -$36.5K 0.03% 315
2024
Q3
$1.66M Buy
3,385
+83
+3% +$38.6K 0.03% 329
2024
Q2
$1.47M Buy
3,302
+2,181
+195% +$869K 0.03% 320
2024
Q1
$427K Sell
1,121
-168
-13% -$63.5K 0.02% 333
2023
Q4
$435K Sell
1,289
-1,225
-49% -$365K 0.02% 329
2023
Q3
$735K Buy
2,514
+1,349
+116% +$421K 0.02% 352
2023
Q2
$398K Buy
1,165
+362
+45% +$110K 0.02% 324
2023
Q1
$205K Buy
803
+450
+127% +$111K 0.01% 394
2022
Q4
$93.7K Sell
353
-135
-28% -$32.9K 0.01% 514
2022
Q3
$91K Sell
488
-90
-16% -$19.3K 0.01% 496
2022
Q2
$116K Buy
578
+110
+24% +$25.8K 0.01% 474
2022
Q1
$141K Buy
468
+38
+9% +$11.1K 0.01% 479
2021
Q4
$154K Buy
430
+31
+8% +$10.7K 0.01% 438
2021
Q3
$132K Sell
399
-24
-6% -$8.06K 0.01% 429
2021
Q2
$130K Sell
423
-114
-21% -$32K 0.01% 409
2021
Q1
$132K Buy
537
+348
+184% +$87.6K 0.01% 392
2020
Q4
$52K Sell
189
-18
-9% -$4.47K ﹤0.01% 505
2020
Q3
$49K Buy
207
+18
+10% +$4.04K 0.01% 469
2020
Q2
$36K Sell
189
-477
-72% -$85.5K ﹤0.01% 468
2020
Q1
$110K Buy
+666
New +$122K 0.02% 316

Other funds holding ISRG

Clearstead Advisors's ISRG Position: Q2 2026 in Review

Clearstead Advisors increased its Intuitive Surgical (ISRG) stake by 76% in Q2 2026, buying an estimated $1.58M and bringing the position to 8,397 shares worth $3.34M. The position accounts for 0.03% of the portfolio, ranked #305.

Clearstead Advisors first reported a position in ISRG in Q1 2020 and has held it in 26 quarters since. The position peaked at $4.73M in Q4 2025. 2,236 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Clearstead Advisors held 8,397 shares of Intuitive Surgical worth $3.34M as of Q2 2026.
  • Clearstead Advisors bought 3,616 Intuitive Surgical shares in Q2 2026, an estimated $1.58M.
  • Intuitive Surgical made up 0.03% of Clearstead Advisors's portfolio in Q2 2026, its #305 holding.
  • Clearstead Advisors first reported a position in Intuitive Surgical in Q1 2020 and has held it in 26 quarters since.
  • Clearstead Advisors's Intuitive Surgical position peaked at $4.73M in Q4 2025.
  • 2,236 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.